Log on / register
Feedback | Support | My details

Pre-publication history

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

Mitchell Gross email, Celestia Higano email, Allan Pantuck email, Olga Castellanos email, Erica Green email, Koo Nguyen email and David B Agus email

BMC Cancer 2007, 7:142doi:10.1186/1471-2407-7-142

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript08 Mar 2007
Reviewer's ReportJonathan Rosenberg13 Apr 2007
Reviewer's ReportWilliam Berry12 Jun 2007
Reviewer's ReportDamian Laber15 Jun 2007
Resubmission - Version 2ManuscriptAuthors' comments28 Jun 2007
Reviewer's ReportDamian Laber12 Jul 2007
Reviewer's ReportJonathan Rosenberg12 Jul 2007
Resubmission - Version 3ManuscriptAuthors' comments24 Jul 2007
Accepted27 Jul 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.